ResearchMoz

Pharmaceuticals and Healthcare Market Research Reports & Industry Analysis

The Pharmaceutical Industry is a key segment for global economical growth. While the industry is dominated ...

Pharmaceuticals and Healthcare

Sub Category

Browse reports in Pharmaceuticals and Healthcare

Displaying 351 to 380 (of 5433 records)
Pages: « Prev  7 8 9 10 11 12 13 14 15 16   Next »
Research on Chinas FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017
Mar 2013   |   By - Huidian Research
According to Huidian’s market research, the output value of China’s FISH probe market in 2012 was about CNY 20 million to CNY 30 million; with the improvement of people’s living standard and medical conditions in the future, FISH probe products will be more and more used in medical diagnosis. The main brands of China’s FISH probe industry are GP, Abbott,...
$2500
Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinsons Disease Treatment will Boost Market Despite Patent Cliff
Mar 2013   |   By - GBI Research
Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinsons Disease Treatment will Boost Market Despite Patent Cliff GBI Research, the leading business intelligence provider, has released its latest research “Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinson’s Disease...
$3500
Healthcare Decision Support and IBM Watson: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019
Mar 2013   |   By - Winter Green Research
WinterGreen Research announces that it has published a new study Healthcare Decision Support and IBM Watson Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 271 pages, 87 tables and figures. Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in...
$3800
Rheumatoid Arthritis Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Rheumatoid Arthritis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Rheumatoid Arthritis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Rheumatoid Arthritis, complete with latest updates, and special features on late-stage and discontinued...
$2500
Type 2 Diabetes Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Type 2 Diabetes Pipeline Review, H1 2013 Summary Global Markets Directs, 'Type 2 Diabetes Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2500
Asthma Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Asthma Pipeline Review, H1 2013 Summary Global Markets Directs, 'Asthma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Asthma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved...
$2000
Multiple Sclerosis Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Multiple Sclerosis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Multiple Sclerosis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Multiple Sclerosis, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Chronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Chronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Chronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with...
$2000
Psoriasis Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Psoriasis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Psoriasis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Neuropathic Pain Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Neuropathic Pain Pipeline Review, H1 2013 Summary Global Markets Directs, 'Neuropathic Pain Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neuropathic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Hypertension Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Hypertension Pipeline Review, H1 2013 Summary Global Markets Directs, 'Hypertension Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Lymphocytic Leukemia...
$2000
Ulcerative Colitis Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Ulcerative Colitis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Ulcerative Colitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ulcerative Colitis, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Transplantation Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Transplantation Pipeline Review, H1 2013 Summary Global Markets Directs, 'Transplantation Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Influenza A Infections Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Influenza A Infections Pipeline Review, H1 2013 Summary Global Markets Directs, 'Influenza A Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Influenza A Infections, complete with latest updates, and special features on late-stage and discontinued...
$2000
Kidney Disease Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Kidney Disease Pipeline Review, H1 2013 Summary Global Markets Directs, 'Kidney Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Gastrointestinal Tract Cancer Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Gastrointestinal Tract Cancer Pipeline Review, H1 2013 Summary Global Markets Directs, 'Gastrointestinal Tract Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Gastrointestinal Tract Cancer, complete with latest updates, and special features on...
$2000
Hepatitis Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Hepatitis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Hepatitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Macular Degeneration Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Macular Degeneration Pipeline Review, H1 2013 Summary Global Markets Directs, 'Macular Degeneration Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Macular Degeneration, complete with latest updates, and special features on late-stage and discontinued...
$2000
Metastatic Cancer Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Metastatic Cancer Pipeline Review, H1 2013 Summary Global Markets Directs, 'Metastatic Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Multiple Myeloma (Kahler's Disease) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Multiple Myeloma (Kahler's Disease) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Multiple Myeloma (Kahler's Disease) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Multiple Myeloma (Kahler's Disease), complete with latest updates, and special...
$2000
Diabetes Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Diabetes Pipeline Review, H1 2013 Summary Global Markets Directs, 'Diabetes Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Metastatic Melanoma Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Metastatic Melanoma Pipeline Review, H1 2013 Summary Global Markets Directs, 'Metastatic Melanoma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Melanoma, complete with latest updates, and special features on late-stage and discontinued projects....
$2000
Glioblastoma Multiforme (GBM) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Glioblastoma Multiforme (GBM) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Glioblastoma Multiforme (GBM) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Glioblastoma Multiforme (GBM), complete with latest updates, and special features on...
$2000
Malaria Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Malaria Pipeline Review, H1 2013 Summary Global Markets Directs, 'Malaria Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Malaria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Chronic Lymphocytic Leukemia (CLL) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Chronic Lymphocytic Leukemia (CLL) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Chronic Lymphocytic Leukemia (CLL) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with latest updates, and special...
$2000
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline Review, H1 2013 Summary Global Markets Directs, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Methicillin-Resistant...
$2000
Neurodegenerative Diseases Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Neurodegenerative Diseases Pipeline Review, H1 2013 Summary Global Markets Directs, 'Neurodegenerative Diseases Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neurodegenerative Diseases, complete with latest updates, and special features on late-stage and...
$2000
Renal Cell Carcinoma Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Renal Cell Carcinoma Pipeline Review, H1 2013 Summary Global Markets Directs, 'Renal Cell Carcinoma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Renal Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued...
$2000
Relapsed Multiple Myeloma Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Relapsed Multiple Myeloma Pipeline Review, H1 2013 Summary Global Markets Directs, 'Relapsed Multiple Myeloma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Relapsed Multiple Myeloma, complete with latest updates, and special features on late-stage and...
$2000
 
Displaying 351 to 380 (of 5433 records)
Pages: « Prev  7 8 9 10 11 12 13 14 15 16   Next »